RAPT Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RAPT and other ETFs, options, and stocks.About RAPT
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
RAPT Key Statistics
Stock Snapshot
As of today, RAPT Therapeutics(RAPT) shares are valued at $57.81. The company's market cap stands at 1.6B, with a P/E ratio of -5.21.
On 2026-02-12, RAPT Therapeutics(RAPT) stock moved within a range of $57.73 to $57.82. With shares now at $57.81, the stock is trading +0.1% above its intraday low and -0.0% below the session's peak.
Trading activity shows a volume of 6.12M, compared to an average daily volume of 5.81M.
The stock's 52-week range extends from a low of $5.67 to a high of $57.86.
The stock's 52-week range extends from a low of $5.67 to a high of $57.86.
Analyst ratings
89%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.